Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA's Reynolds Marks Top GMP Trouble Spots As Deadline Looms

This article was originally published in The Tan Sheet

Executive Summary

Some dietary supplement firms will not be ready to comply with good manufacturing practices by the rapidly approaching final deadline, according to a senior FDA advisor on supplement products
Advertisement

Related Content

Pharmavite, FDA Offer Alternate Takes On GMP Compliance Strategy
FDA Measures Supplement Firms' GMP Recordkeeping Burden
As Supplement GMP Implementation Hits Zero Hour, Small Firms Still Struggle
SIDI Group Expects "Passport" To Business Growth With Standardized CofA
First GMP Warning Letter Reflects FDA's List Of Major Concerns
Research & Development In Brief
FDA's Frankos Grades GMP Complaint Recordkeeping "Needs Improvement"
FDA Will Rev GMP Inspections Of Medium Supplement Firms, After A Pause
FDA Will Rev GMP Inspections Of Medium Supplement Firms, After A Pause
Looming GMPs Could Doom Some Firms Unless Industry, FDA Lend Support

Topics

Advertisement
UsernamePublicRestriction

Register

PS104088

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel